It’s almost exactly a year since we learned that Apple was making ResearchKit available to big pharmaceutical companies and GlaxoSmithKline would be using the platform to carry out clinical studies. GSX has now announced the first of those studies.
The study will use the GSK PARADE iPhone app to conduct surveys and use iPhone sensors to collect and track common symptoms of rheumatoid arthritis: joint pain, fatigue, and mood. It will also track activity and quality of life measures for 300 patients over a three-month period.
The company says that it sees significant benefits by collecting data via ResearchKit …
more…Filed under: Apple
